
LuminUltra expands testing capacity including range of COVID-19 offerings with acquisition of Source Molecular Corporation
FREDERICTON, NB, November 30, 2020 – Biotechnology front-runner LuminUltra today announced the acquisition of Source Molecular Corporation, a leader in lab-based testing solutions for microbial source tracking of pathogens including SARS-CoV-2, the virus that causes COVID-19. With this acquisition, LuminUltra has further expanded its range of molecular testing options for a variety of uses cases…. Read More